Please login to the form below

Not currently logged in
Email:
Password:

real-world data

This page shows the latest real-world data news and features for those working in and with pharma, biotech and healthcare.

EMA forges closer ties with HTA umbrella group

EMA forges closer ties with HTA umbrella group

The two organisations will also collaborate on the development of post-licensing evidence-generating tools, such as patient registries that can be used to create real-world data, and the exchange ... of that data.

Latest news

  • Smartphone monitoring shows its worth in Roche MS trial Smartphone monitoring shows its worth in Roche MS trial

    The latest results from the FLOODLIGHT clinical trial programme show that additional, real-world data using smartphone or smartwatch technology given to patients treated with Roche’s MS therapy Ocrevus (ocrelizumab), ... tool “enables a continuous

  • Europe’s cancer drug regulation is ‘broken’, claims study Europe’s cancer drug regulation is ‘broken’, claims study

    clinical trials rather than real world data on actual patient outcomes”. ... It added: “To help determine how medicines will function in a real world setting surrogate endpoints - often laboratory tests indicative of an expected improvement - often

  • Merck to co-lead new oncology big data alliance Merck to co-lead new oncology big data alliance

    Project Data Sphere’s existing digital platform already contains clinical trial data from almost 100, 000 patients. ... The GOBDA will expand this platform to include rare tumour trial, experimental arm and real-world patient data, looking to combine

  • Prix Galien opens for entries with new award

    The inaugural Real World Evidence Award was won by Dificlir, Astellas’treatment for clostridium difficile infection. ... It will recognise excellence in the generation, collection and application of observational data to demonstrate health outcomes,

  • Amgen real world study and mobile data partnership Amgen real world study and mobile data partnership

    Amgen real world study and mobile data partnership. Will work with health and wellbeing group Humana on risk prevention. ... Initially targeting multiple conditions, including cardiovascular disease, osteoporosis, neurologic disorders, inflammatory

More from news
Approximately 12 fully matching, plus 81 partially matching documents found.

Latest Intelligence

  • The real-world data conundrum The real-world data conundrum

    The stakeholders. At the forefront of innovation around real-world data is the industry. ... The value of real-world data to payers is that it increases the certainty about the effectiveness of the product that they’re buying.

  • Pulling together Pulling together

    The real world and data. One aspect of the UK that both the government and industry are keen to talk up is its health service and the opportunity of working with ... Launched in 2012 it was the first time a large, prospective real-world study was

  • Exploring serious market access roadblocks for rare bleeding disorders Exploring serious market access roadblocks for rare bleeding disorders

    In order to collect this data, we need to emphasise the importance of real-world data - a process which is useful in many phases of product development. ... Real-world research incorporates randomised controlled trials (RCTs) and ‘more pragmatic

  • Proving real-world value Proving real-world value

    An R&D model enhanced by real-world data ensures momentum to market. ... Then, when that product is being reviewed in Truro or even in France, we can share data of how it’s being used in its real-world population.

  • Embracing digital disruption in pharma Embracing digital disruption in pharma

    Another important dimension is the collection of real-world data. As a pharma company, LEO’s contact points directly with users have historically been limited, but we can fill that gap ... of usable real-world data.

More from intelligence
Approximately 5 fully matching, plus 43 partially matching documents found.

Latest appointments

  • Astellas appoints new senior VP Astellas appoints new senior VP

    pioneered multiple real-world data endeavours and built research partnerships with academic and managed care organisations.

  • Dr Ameet Nathwani moves from Novartis to Sanofi Dr Ameet Nathwani moves from Novartis to Sanofi

    Oliver Brandicourt, Sanofi's chief executive officer, said: “ Our industry is experiencing increased pressure to support reimbursement with customized data from real-world evidence, demonstrate ongoing benefit-risk of registered products

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Latest intelligence

Shining a light on the true cost of patient care
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS...
city
The real-world data conundrum
How data is changing the healthcare industries...
Where is health behaviour change heading?
Cures rely on patient adherence to succeed, and health behaviour change in any non-compliant patient is essential, this post explores where health behaviour change is heading....

Infographics